Log In
Print
BCIQ
Print
Print this Print this
 

Simbrinza, brinzolamide/brimonidine tartrate

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionFixed combination of brinzolamide, a carbonic anhydrase II (CAII) inhibitor, and brimonidine tartrate, a relatively selective adrenergic receptor alpha 2 (ADRA2) agonist
Molecular Target Carbonic anhydrase II (CAII) ; Adrenergic receptor alpha 2 (ADRA2)
Mechanism of ActionAdrenergic receptor alpha 2 (ADRA2) agonist; Carbonic anhydrase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOcular hypertension
Indication DetailsTreat intraocular pressure in patients with glaucoma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today